Stay updated on Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T20:27:02.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 Forbidden page, where the study record remains unavailable.
    Difference
    0.2%
    Check dated 2026-10-18T22:32:58.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.0 to v3.7.1, while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T22:22:35.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error page with basic HTML structure and a Home link, replacing the previous detailed study record content.
    Difference
    19%
    Check dated 2026-09-20T20:38:40.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.6, replacing the previous v3.6.5. This indicates a minor site update and does not change the study content or page functionality.
    Difference
    0.1%
    Check dated 2026-08-30T12:02:57.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    Revision updated from v3.6.4 to v3.6.5, indicating a minor page update. The change does not modify trial data or how the page functions.
    Difference
    0.1%
    Check dated 2026-08-09T00:32:44.000Z thumbnail image

Stay in the know with updates to Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.